Table of Contents
Table of Contents
Preface
Biological Treatments in Autoimmune Rheumatic Diseases
Chapter 1. Biologic Therapies for Systemic Lupus Erythematosus
Maria Mouyis, Coziana Ciurtin and David A. Isenberg (Northwick Park University Hospital, London, UK, and others)
Chapter 2. Biologics in Juvenile Systemic Lupus Erythematosus
Claire-Louise Murphy and Nicola Ambrose (University College London Hospital, London, UK)
Chapter 3. Biologic Treatments for Idiopathic Inflammatory Myopathies
Serena Fasano and David A. Isenberg (Second University of Naples, Naples, Italy)
Chapter 4. Biologic Treatment Advances in Sjӧgren’s Syndrome: Understanding the Implications of using Biologic Therapies in Selected Categories of Patients
Coziana Ciurtin, Nicolyn Thompson and David A. Isenberg (University College London, London, UK)
Chapter 5. Biologic Therapies in Systemic Sclerosis
Svetlana Nihtyanova and Christopher P. Denton (UCL Medical School, Royal Free Campus, London, UK)
Chapter 6. The Role of Biologics in the Treatment of Small and Medium Vessel Vasculitis
Lubna Ghani and Eleana Ntatsaki (Royal Free Hospital, London, UK, and others)
Chapter 7. Imaging and Pathogenesis in Large Vessel Vasculitis: Early Lessons for Biologic Treatments
Philip P. Stapleton, Katerina Achilleos, Dimos Merinopoulos, and Bhaskar Dasgupta (Southend University Hospital, Essex, UK)
Chapter 8. Biologics in Behçet Syndrome
Emon Khan (University College London, London, UK)
Biologic Treatments in Chronic Inflammation Arthritides
Chapter 9. Tumour Necrosis Factor Inhibitors used in the Treatment of Rheumatoid Arthritis: Evidence of Safety, Efficacy and Health Implication
Laura Attipoe, Katie Bechman and Coziana Ciurtin (University College London Hospital, London, UK, and others)
Chapter 10. Biologic Treatments (Other than Anti-TNF Therapy) Licensed for Use in Rheumatoid Arthritis
Laura Attipoe, Katie Bechman and Coziana Ciurtin (University College London Hospital, London, UK, and others)
Chapter 11. New Biologic Agents and Biosimilars Developed for Rheumatoid Arthritis
Laura Attipoe, Katie Bechman and Coziana Ciurtin (University College London Hospital, London, UK, and others)
Chapter 12. Biologics in Spondyloarthritis
Mediola Ismajli and Maria Leandro (University College London Hospital, London, UK)
Chapter 13. Established and New Biologic Therapies for Psoriatic Arthritis and Psoriasis
Benjamin J Thomas, Sarah Elyoussi and Coziana Ciurtin (UCL Medical School, London, UK, and others)
Chapter 14. Biologics in Juvenile Idiopathic Arthritis
Charalampia Papadopoulou and Nicola Ambrose (Institute of Child Health, UCL, London, UK, and others)
Miscellanea
Chapter 15. Biologic Disease Modifying Anti-Rheumatic Drugs in Pregnancy and Breast-Feeding Period
Hanh Nguyen and Ian Giles (University College London, London, UK)
Chapter 16. Biologic Therapy in Osteoporosis: New Developments, Clinical uses and Health Implications
Maria Mouyis and Judith Bubbear (Northwick Park Hospital, London, UK, and others)
Chapter 17. Biologic Treatments for Pulmonary Involvement in Rheumatic Disease
Helen S. Garthwaite and Joanna C. Porter (University College London, London, UK)
Chapter 18. Additional Benefits of Tumour Necrosis Factor Inhibitor Therapies
Angela Pakozdi and Vanessa Morris (University College London, London, UK)
Chapter 19. Infection and Biologics
Maria Krutikov and Jessica Manson (University College London, London, UK)
Chapter 20. Participant Information Sheets in Clinical Research: Compromising the Ethics of Informed Consent?
Andra Negoescu, and Leslie Gelling (Addenbrooke’s Hospital, Cambridge, UK, and others)
Chapter 21. Biologic Treatment: The Young Patients’ Perspective
Nicola Daly (University College London, London, UK)
Chapter 22. Strategies and Safety Nets: Nurse-Led Care of the Patient on Biologics
Pauline Buck and Victoria Howard (University College London, London, UK)
Index
The book is aimed at specialist doctors, trainees, nurses and health professionals working in the field of rheumatology.
